SAGE -6% on 3-month PDUFA extension to 3/19/19: https://finance.yahoo.com/news/sage-therapeutics-receives-notification-pdufa-123000559.html What a hilariously overvalued company--5 billion dollars for a bunch of drugs entering a market crowded with abundant generics?